Xing Liu & Wenwen Shen. (2024). Trastuzumab-functionalized SK-BR-3 cell membrane-wrapped mesoporous silica nanoparticles loaded with pyrotinib for the targeted therapy of HER-2-positive breast cancer. Elsevier.
Chicago Style (17th ed.) CitationXing Liu and Wenwen Shen. Trastuzumab-functionalized SK-BR-3 Cell Membrane-wrapped Mesoporous Silica Nanoparticles Loaded with Pyrotinib for the Targeted Therapy of HER-2-positive Breast Cancer. Elsevier, 2024.
MLA (9th ed.) CitationXing Liu and Wenwen Shen. Trastuzumab-functionalized SK-BR-3 Cell Membrane-wrapped Mesoporous Silica Nanoparticles Loaded with Pyrotinib for the Targeted Therapy of HER-2-positive Breast Cancer. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.